INITIAL FUNDING, RFP #N02-CM-37002-05, DTP-13-015, 02/01/2013 - 01/31/2014, SHE

癌症治疗和诊断司(DCTD)的活动重点是开发癌症的新诊断和治疗方法。DCTD的工作人员与国家癌症研究所(NCI)、学术界和工业界的同事一起，正在努力建立一个无缝的生物标记物和治疗流水线，从最初的药物发现努力到后期临床试验。随着图像引导诊断和图像引导治疗的进步不断涌现，新的癌症成像技术在支持这一管道方面发挥了关键作用。

The Division of Cancer Treatment and Diagnosis (DCTD) focuses its activities on developing novel diagnostics and therapies for cancer. DCTD staff members, along with colleagues throughout the National Cancer Institute (NCI), academia, and industry, are working to generate a seamless pipeline of biomarkers and therapeutics that runs the gamut from initial efforts in drug discovery through late-stage clinical trials. New cancer imaging techniques play a critical role in support of this pipeline as advances in image-guided diagnosis and image-guided therapies continue to emerge.